Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
50 | 3 | PSYCHIATRY//SCHIZOPHRENIA//PSYCHIAT | 98837 |
1821 | 2 | LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 | 6552 |
3840 | 1 | GLYCOGEN SYNTHASE KINASE 3//GSK 3//GLYCOGEN SYNTHASE KINASE 3 BETA | 1935 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | GLYCOGEN SYNTHASE KINASE 3 | authKW | 1227309 | 10% | 39% | 191 |
2 | GSK 3 | authKW | 760493 | 7% | 34% | 136 |
3 | GLYCOGEN SYNTHASE KINASE 3 BETA | authKW | 669165 | 8% | 27% | 154 |
4 | GSK 3 BETA | authKW | 414924 | 7% | 20% | 130 |
5 | GSK 3 INHIBITORS | authKW | 409393 | 1% | 93% | 27 |
6 | GLYCOGEN SYNTHASE KINASE 3 GSK 3 | authKW | 238206 | 2% | 46% | 32 |
7 | LITHIUM | authKW | 198219 | 15% | 4% | 286 |
8 | GSK3 BETA | authKW | 195335 | 4% | 16% | 77 |
9 | TDZD 8 | authKW | 183210 | 1% | 75% | 15 |
10 | GSK3 | authKW | 154345 | 3% | 17% | 55 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Neurosciences | 5483 | 32% | 0% | 619 |
2 | Psychiatry | 1847 | 12% | 0% | 233 |
3 | Biochemistry & Molecular Biology | 1717 | 27% | 0% | 532 |
4 | Chemistry, Medicinal | 1636 | 9% | 0% | 179 |
5 | Cell Biology | 1161 | 14% | 0% | 275 |
6 | Pharmacology & Pharmacy | 990 | 15% | 0% | 297 |
7 | Clinical Neurology | 333 | 7% | 0% | 140 |
8 | Oncology | 238 | 8% | 0% | 153 |
9 | Biophysics | 104 | 4% | 0% | 73 |
10 | Behavioral Sciences | 48 | 2% | 0% | 31 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PSYCHIAT BEHAV NEUROBIOL | 124848 | 3% | 12% | 62 |
2 | MOL NEUROBIOL SECT | 115264 | 2% | 20% | 35 |
3 | EXPT MED NEPHROL CRIT CARE MED | 81430 | 0% | 100% | 5 |
4 | SPARKS 1057 | 72972 | 1% | 41% | 11 |
5 | SPARKS | 46934 | 0% | 41% | 7 |
6 | COMMUNITY HLTH PROFESS | 45234 | 0% | 56% | 5 |
7 | MOL PATHOPHYSIOL | 38619 | 2% | 8% | 30 |
8 | NEUROSIGNALLING GRP | 36642 | 0% | 75% | 3 |
9 | GORDON MED IMAGING NUCL MED MOL IMAGING | 32572 | 0% | 100% | 2 |
10 | MOL PATHOPHYSIOL MOOD ANXIETY DISORDERS PRO | 32572 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | FRONTIERS IN MOLECULAR NEUROSCIENCE | 9737 | 1% | 3% | 22 |
2 | BIPOLAR DISORDERS | 4761 | 1% | 1% | 20 |
3 | CURRENT ALZHEIMER RESEARCH | 2231 | 1% | 1% | 12 |
4 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 1978 | 1% | 1% | 15 |
5 | JOURNAL OF NEUROCHEMISTRY | 1565 | 2% | 0% | 46 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1561 | 3% | 0% | 51 |
7 | MOLECULAR PSYCHIATRY | 1124 | 1% | 1% | 13 |
8 | CHEMICAL BIOLOGY & DRUG DESIGN | 1094 | 1% | 1% | 11 |
9 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1023 | 1% | 0% | 18 |
10 | ACS CHEMICAL NEUROSCIENCE | 964 | 0% | 1% | 8 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLYCOGEN SYNTHASE KINASE 3 | 1227309 | 10% | 39% | 191 | Search GLYCOGEN+SYNTHASE+KINASE+3 | Search GLYCOGEN+SYNTHASE+KINASE+3 |
2 | GSK 3 | 760493 | 7% | 34% | 136 | Search GSK+3 | Search GSK+3 |
3 | GLYCOGEN SYNTHASE KINASE 3 BETA | 669165 | 8% | 27% | 154 | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA |
4 | GSK 3 BETA | 414924 | 7% | 20% | 130 | Search GSK+3+BETA | Search GSK+3+BETA |
5 | GSK 3 INHIBITORS | 409393 | 1% | 93% | 27 | Search GSK+3+INHIBITORS | Search GSK+3+INHIBITORS |
6 | GLYCOGEN SYNTHASE KINASE 3 GSK 3 | 238206 | 2% | 46% | 32 | Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3 | Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3 |
7 | LITHIUM | 198219 | 15% | 4% | 286 | Search LITHIUM | Search LITHIUM |
8 | GSK3 BETA | 195335 | 4% | 16% | 77 | Search GSK3+BETA | Search GSK3+BETA |
9 | TDZD 8 | 183210 | 1% | 75% | 15 | Search TDZD+8 | Search TDZD+8 |
10 | GSK3 | 154345 | 3% | 17% | 55 | Search GSK3 | Search GSK3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |